China Money Network
Login
Join

OrbiMed Asia Leads $19M Series B Round In Biotech Start-Up InventisBio

  • May 31, 2017 — 10:00 CST

This Data Is Locked!

This area is available only to Subscribers.

Healthcare-focused investment firm OrbiMed Asia Partners has led a US$19 million series B round of financing in InventisBio, a biotech company dedicated to the discovery... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: